Related Experiment Video
Updated: Feb 2, 2026

In Vivo Two-photon Imaging of Megakaryocytes and Proplatelets in the Mouse Skull Bone Marrow
Published on: July 28, 2021
Megakaryocyte Contribution to Bone Marrow Fibrosis: many Arrows in the Quiver
Alessandro Malara1,2, Vittorio Abbonante1,2, Maria Zingariello3
1Department of Molecular Medicine, University of Pavia, Pavia, Italy.
Abstract:
In Primary Myelofibrosis (PMF), megakaryocyte dysplasia/hyperplasia determines the release of inflammatory cytokines that, in turn, stimulate stromal cells and induce bone marrow fibrosis. The pathogenic mechanism and the cells responsible for progression to bone marrow fibrosis in PMF are not completely understood. This review article aims to provide an overview of the crucial role of megakaryocytes in myelofibrosis by discussing the role and the altered secretion of megakaryocyte-derived soluble factors, enzymes and extracellular matrices that are known to induce bone marrow fibrosis.
Insights
In Primary Myelofibrosis (PMF), abnormal megakaryocytes drive fibrosis by releasing inflammatory factors. This review explores how these cells and their secretions contribute to bone marrow fibrosis progression.
Area of Science:
- Hematology
- Oncology
- Pathology
Background:
- Primary Myelofibrosis (PMF) is characterized by bone marrow fibrosis.
- Megakaryocyte abnormalities are implicated in PMF pathogenesis.
- The precise mechanisms driving fibrosis in PMF remain incompletely understood.
Purpose of the Study:
- To review the critical role of megakaryocytes in the development of myelofibrosis.
- To elucidate the contribution of megakaryocyte-derived factors to bone marrow fibrosis.
Main Methods:
- Literature review of studies on megakaryocytes and myelofibrosis.
- Analysis of research on soluble factors, enzymes, and extracellular matrices secreted by megakaryocytes.
- Synthesis of current understanding of PMF pathogenesis.
Main Results:
- Megakaryocyte dysplasia and hyperplasia are key drivers of inflammatory cytokine release in PMF.
- These cytokines activate stromal cells, promoting bone marrow fibrosis.
- Altered megakaryocyte-derived soluble factors, enzymes, and extracellular matrices contribute significantly to fibrosis.
Conclusions:
- Megakaryocytes play a central role in the progression of bone marrow fibrosis in PMF.
- Understanding megakaryocyte-driven mechanisms is crucial for developing targeted therapies for PMF.
Related Concept Videos
Bone Marrow Sampling and Transplants
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
Binet's Contribution to Measures of Intelligence
Wechsler's Contribution to Measures of Intelligence
Cystic Fibrosis: Pathogenesis
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
Cystic Fibrosis: Management
Sinus disease and chronic...
Bone Structure

